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Association of Genetic and Environmental Risks
for Attention-Deficit/Hyperactivity Disorder
With Hypomanic Symptoms in Youths
Georgina M. Hosang, PhD; Paul Lichtenstein, PhD; Angelica Ronald, PhD;
Sebastian Lundström, PhD; Mark J. Taylor, PhD
IMPORTANCE Attention-deficit/hyperactivity disorder (ADHD) and bipolar disorder are highly
comorbid, with significantly associated symptoms. Themechanisms that account for their
co-occurrence are not known.
OBJECTIVE To examine the degree to which genetic and environmental risk factors for ADHD
traits, across childhood and adolescence, are associated with adolescent hypomanic
symptoms.
DESIGN, SETTING, AND PARTICIPANTS This study used data on 13 532 twin pairs from the Child
and Adolescent Twin Study in Sweden, a prospective, longitudinal twin study. Their parents
provided ADHD data when children were 9 or 12 years of age. Of those who reached 15 years
of age, 3784 participated. Of those who reached 18 years of age, 3013 participated. The study
was performed fromDecember 20, 2017, to December 5, 2018. Data analysis was performed
at the Department of Medical Epidemiology & Biostatistics, Karolinska Institutet, Stockholm,
Sweden, fromMarch 1, 2018, to October 31, 2018.
MAIN OUTCOMES ANDMEASURES Attention-deficit/hyperactivity disorder traits and
hypomanic symptoms were assessed using parent-rated instruments. Associations between
ADHD and adolescent hypomanic symptoms across childhood and adolescence were
investigated using generalized estimating equations. Multivariate twin models were used to
examine the extent to which genetic and environmental risk factors for ADHDwere
associated with hypomania.
RESULTS Among 3784 15-year-old twin pairs and 3013 18-year-old twin pairs, ADHD and
hypomanic symptoms were significantly associated (age 15 years: β = 0.30; 95% CI,
0.24-0.34; P < .001; age 18 years: β = 0.19; 95% CI, 0.16-0.22; P < .001), especially for the
hyperactivity-impulsivity ADHD symptom domain (age 15 years: β = 0.53; 95% CI, 0.46-0.60;
P < .001; age 18 years: β = 0.36; 95% CI, 0.30-0.42; P < .001) compared with the inattention
domain (age 15 years: β = 0.40; 95% CI, 0.34-0.47; P < .001; age 18 years: β = 0.24; 95% CI,
0.19-0.29; P < .001). Between 13% and 29% of the genetic risk factors for hypomania were
also associated with ADHD, with higher estimates detected for symptoms of
hyperactivity-impulsivity (10%-25%) compared with inattention (6%-16%). Environmental
factors played a negligible role in the associations. Genetic factors unique to adolescent
hypomania were associated with 25% to 42% of its variance, suggesting some etiologic
distinction between these forms of psychopathology.
CONCLUSIONS AND RELEVANCE More than a quarter of the genetic risk factors for adolescent
hypomanic traits were also associated with ADHD symptoms in childhood and adolescence,
with hypomania-specific genetic risk factors detected. These findings suggest that ADHD and
hypomanic symptoms are associated with shared genetic factors, which should be the focus
of further research.
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E arly identification of individuals at high risk of bi-polar disorder (BD) is essential for prevention andintervention1 and can be aided by investigating hypo-
manic symptoms in youths. Bipolar disorder is characterized
by hypomanic or manic episodes. Hypomania is common in
youths, with up to 10% identified as being at high risk of BD
based on the clustering, duration, and impairment of
symptoms.2Subsyndromalhypomanicsymptomsortraitshave
been linked to subsequentmanic or hypomanic episodes and
BD onset.3
There is evidence thatBD isprecededbychildhoodADHD;
apopulation-based study4 foundhigher incidence rates of BD
among those with a history of ADHD (incidence rate, 23.86)
compared with those without (incidence rate, 2.17). The co-
morbidity rates of BD-ADHD are higher than expected by
chance5; theweightedmean prevalence of ADHD in pediatric
bipolar samples is 48%.6 A study7 that used modified BD di-
agnostic criteria characterized by nonepisodic irritability and
ultrarapidcycling inpediatric samples reportedhighADHD-BD
comorbidity rates of 74% to 98%. The focus on nonepisodic
irritability, which also covers temper outbursts and emotion
dysregulation,mayhave increased thesecomorbidity ratesbe-
cause such symptoms are associated features of ADHD.7,8 Af-
ter much debate, there is some consensus that nonepisodic
irritability is more characteristic of severe mood dysregula-
tionordisruptivedysregulationdisorder rather thanBD.8Thus,
care needs to be taken to differentiate between BD and these
syndromes.
Significant, modest correlations between adolescent hy-
pomanic and hyperactivity symptoms have also been
reported.2,9 The ADHD symptom domains of hyperactivity-
impulsivity and inattention may be differentially associated
with BD. One study10 found that BDwas associatedwith inat-
tentive and combined but not hyperactive-impulsive ADHD
presentations. Others11,12 have reported similar levels of inat-
tention and hyperactivity-impulsivity in patients with BD.
These disparate findings need to be addressed with further
research.Theco-occurrenceofADHDandBDisassociatedwith
worseoutcomes, includinghigher ratesof comorbidityandsui-
cide attempts, comparedwithBDorADHDalone.11-13 It is cru-
cial to determine the origins of the ADHD-BD overlap, distin-
guishing inattention fromhyperactivity-impulsivity, to avoid
such outcomes.
Shared genetic risk factors are postulated to be partly
responsible for the ADHD-BD association and their related
symptoms. A moderate genetic correlation between ADHD
and BD II using family data has been reported.14 That study14
focused on BD not hypomania and did not distinguish
between the ADHD presentations. The sample had a broad
age range; thus, it is unclear whether the results apply to dif-
ferent age groups. Research focused on childhood and ado-
lescence would be useful because the initial emergence of
psychopathologic symptoms occurs at these developmental
stages. This was the first twin study, to our knowledge, to
explore the extent to which genetic and environmental risk
factors for hypomanic traits are associated with ADHD symp-
toms in youths, examining inattention and hyperactivity-
impulsivity separately.
Methods
Participants
This twin study used data from 13 532 twin pairs who partici-
pated in theChildandAdolescentTwinStudy inSweden,a lon-
gitudinal, prospective twin study performed from December
20, 2017, toDecember 5, 2018.15 Their parentsprovidedADHD
data when children were 9 or 12 years of age (response rate,
75%; 3951 monozygotic [MZ] twins and 9581 dizygotic [DZ]
twins). Of those who reached 15 years of age, 3784 partici-
pated (response rate of those eligible, 61%; 1115MZ twins and
2669 DZ twins). Of those who reached 18 years or older, 3013
participated (responserateof thoseeligible, 59%;983MZtwins
and 2030 DZ twins). Pairs were excluded if either twin had a
known brain injury or chromosomal disorder (n = 207). Data
analysis was performed at the Department of Medical Epide-
miology&Biostatistics,Karolinska Institutet, Stockholm,Swe-
den, from March 1, 2018, to October 31, 2018. Parents pro-
vided consent for themselves and their children toparticipate
at9or 12yearsofage,andthetwinsandtheirparentsgavesepa-
rate written informed consent at subsequent waves after re-
ceiving the studydescription. The studywas approvedby the
Karolinska Institutet Ethical ReviewBoard. All datawere dei-
dentified.
Measures
Hypomania was assessed at 15 years of age using the parent-
rated Child Mania Rating Scale (CMRS),16 which distinguishes
children with BD from children with ADHD and healthy con-
trol individuals with high sensitivity (sensitivity for children
with ADHD, 0.84; sensitivity for controls, 0.90) and specific-
ity (specificity for children with ADHD, 0.92; specificity for
controls, 0.96).16 The parent-rated Mood Disorders
Questionnaire17 was used to assess hypomanic symptoms at
18 years of age, with high sensitivity (sensitivity, 0.72) and
specificity (specificity, 0.81) in identifying adolescent BD.17
Both instruments cover symptoms that are more specific to
mania (eg, hypersexuality and grandiosity) compared with
other forms of psychopathology (ADHD).18 Further details of
all measures are presented in eTable 1 in the Supplement.
Key Points
Question Do symptoms of attention-deficit/hyperactivity
disorder and hypomania share genetic and environmental risk
factors in young people?
Findings In this twin study of 13 532 Swedish twin pairs aged 9
and 12 years at enrollment, up to 29% of the variance for
hypomanic symptoms was associated with genetic risk factors
shared with attention-deficit/hyperactivity disorder traits, with
differing estimates detected for hyperactivity-impulsivity (up to
25%) compared with inattention (up to 16%) attention-deficit/
hyperactivity disorder symptom domains.
Meaning Attention-deficit/hyperactivity disorder and hypomanic
symptoms appear to be associated with similar genetic factors.
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The ADHD symptoms at 9 and 12 years of age were as-
sessedusing theAutism-Tics, ADHD, andOther Comorbidities
Inventory (A-TAC),19 a structured telephone interview com-
pletedbyparents. TheA-TACADHDdomain consists of impul-
sivity and activity aswell as concentration and attentionmod-
ules,correspondingtotheDSM-IVADHDcriteria.19Parentsrated
ADHD symptoms when the twins were 15 years of age using
the Strengths and Difficulties Questionnaire hyperactivity
subscale,20 and the ADHD DSM-IV subscale of the Adult Be-
havior Checklist21 was used when twins were 18 years of age.
The Adult Behavior Checklist was divided into hyperactivity-
impulsivity (6 items) and inattention (7 items) domains based
on similarity withDSM-5 criteria.
ParticipantswhohadreceivedanADHD(InternationalSta-
tistical Classification of Diseases andRelatedHealth Problems,
TenthRevision (ICD-10) code,F90)and/orBDdiagnosis (ICD-10
codes,F30-F31)were identifiedusing theSwedishNationalPa-
tientRegister,22which records all specialist inpatient andout-
patient care given to residents of Sweden. Cases of BD were
also identified through lithium prescriptions using the Pre-
scribed Drug Register,23 which covers all medications pre-
scribed to residents of Sweden since 2005.
Statistical Analysis
Positively skewed variables were log-transformed. The birth
year associationswere includedasa covariate inall twinanaly-
ses, andmeans were permitted to differ by sex to account for
meansexdifferences.Participantswere split intogroupsbased
on published cutoffs for the hypomania (CMRS: score of ≥10;
MoodDisordersQuestionnaire:minimumof≥7symptomsclus-
tered in same periodwith at least moderate impairment) and
ADHD (A-TAC: broad cutoff: ≥6; strict cutoff: ≥12) instru-
ments (eTable 1 in the Supplement). In separate analyses, par-
ticipants who received an ADHD and/or BD diagnosis in the
Swedish National Patient Register (and/or a prescription of
lithium in the Prescribed Drug Register for BD) were com-
pared with those without such diagnoses. To test whether
ADHD traits at each age (number of symptoms, screening di-
agnoses, and clinical diagnoses) were associated with hypo-
manic traits at 15 and 18years of age, linear regressionswithin
generalizedestimatingequations (GEEs)wereperformedwith
ADHD as the exposure and hypomania the outcome. This ap-
proach allows for clustering of related individuals and calcu-
lates robustSEs.Toassess theassociationsbetweeneachADHD
diagnosis andhigh riskofBD,we implemented logistic regres-
sions that calculated odds ratioswithin aGEE framework, ad-
justing for sex and birth year. The GEEswere implemented in
the drgee package of R.24 A 1-sided P < .05 was considered to
be statistically significant.
Twin Analyses
The classic twinmethodwasused to investigate thedegree to
which genetic and environmental risk factors for ADHD traits
were associatedwith hypomanic symptoms. Thismethod re-
liesoncomparingthecorrelationsbetweenMZtwinswhoshare
all their segregating DNA code and DZ twins who share ap-
proximately 50% of their segregating DNA code. On the basis
of this information, variance in andamongphenotypes canbe
decomposed into additive genetic risk factors (A), nonaddi-
tive genetic risk factors (D), common or shared environmen-
tal risk factors (C; common to both twins and increase their
similarity), and nonshared or unique environmental risk fac-
tors (E; relatedtoenvironmental factors thatdifferacross twins,
includingmeasurement error).25 The general principles of the
twin design are described in detail elsewhere.25 Cross-trait
cross-twin correlations involve correlating one twin’s ADHD
scorewiththeirco-twin’shypomaniascore;bycalculatingthese
correlations separately for MZ and DZ twins, the degree to
which genetic and environmental factors affect the covari-
ance between ADHD and hypomania can be estimated. The
eMethods in the Supplement give the analytic codes used in
the analyses.
Univariatemodelswere used to assess the relative contri-
bution of A, D, C, and E to each measure and to test assump-
tions of the twindesign.Weassessedwhether genetic anden-
vironmental risk factors for ADHD traits are associated with
hypomania by fitting amultivariate Cholesky decomposition
to the data (Figure 1). The proportion of variance in each trait
that was associated with A, D, C, and E was estimated. Vari-
ance in hypomania that is associatedwith genetic risk factors
for ADHDwas also estimated (the pathways from latent vari-
ables A1, A2, andA4 to the hypomania scales in Figure 1). The
pathway fromvariableA3 tohypomania at 15 years of age rep-
resents the proportion of genetic variance in hypomania at 15
years of age that was independent of ADHD traits. Hypoma-
nia at 18 years of age is associatedwith genetic risk factors for
ADHD traits (A1, A2, and A4), genetic risk factors are associ-
ated with hypomania at 15 years of age (A3), and genetic risk
factors unique to hypomania at 18 years of age (A5). Equiva-
lentpathwaysare included forC,D,andE.Squaring thesepath-
ways gives the proportion of variance in each trait accounted
for by each pathway.26
Figure 1. Path Diagram for Cholesky Decomposition
ADHD
at age 9
or 12 y
A1
ADHD
at age
15 y
A2
Hypomania
at age
15 y
A3
ADHD
at age
18 y
A4
Hypomania
at age
18 y
A5
The pathways from the latent variables (enclosed in circles) labeled A1, A2, and
A4 to the 2 hypomania scales estimate the proportion of variation in hypomania
that is associated with genetic risk factors for attention-deficit/hyperactivity
disorder (ADHD) traits at 9, 12, 15, and 18 years of age. The pathway from A3 to
hypomania at 15 years of age represents the proportion of genetic variance in
hypomania at 15 years of age that is independent of ADHD traits. Hypomania at
18 years of age was associated with genetic risk factors for ADHD traits at each
age (A1, A2, and A4), genetic risk factors for hypomania at 15 years of age (A3),
and genetic factors that are unique to hypomania at 18 years of age (A5).
Equivalent pathways are included for C, D, and E.
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Because univariate analysis implicated C for hypomania
and not ADHD, we fitted a model in which A, D, and E were
associated with ADHD and A, C, and E were associated with
hypomania (CandDdidnotcontribute to thecovarianceamong
phenotypes in thismodel), aswell as the A, C, and E andA, D,
andEmodels.WheneverDwas estimated, sibling interaction
paths were also included in the model because these factors
canmimic that of Dwith twin correlations and are implicated
when the assumptionof equal variances across zygosity is not
met. Eachmodel was fitted with separate variance and cova-
riancecomponentsbysex (quantitativesex limitation).Thesig-
nificance of these sex differences was tested by constraining
all pathways tobeequal by sex.We tested furthernestedmod-
els to assess the significance of individual groups of variance
and covariance components. Model fit was assessed using
Bayesian information criteria,which outperforms alternative
fit statisticswhen fittingmultivariatemodels to large samples.
Lower Bayesian information criteria values indicate better
fittingmodels.27All analyseswere repeated for bothADHDdi-
mensions. The Strengths and Difficulties Questionnaire hy-
peractivity scale was omitted from these analyses because it
only covers hyperactivity.
Results
Atotal of 13 532 twinpairs (3951MZ twins, 9581DZ twins, 2031
female MZ pairs, 1920 male MZ pairs, 22231 female DZ pairs,
2582 male DZ pairs, and 4778 opposite-sex DZ pairs) partici-
pated in this study at 9 or 12 years of age, with 3784 followed
up at 15 years of age and 3013 at 18 years or older. Thedescrip-
tive statistics by sex andzygosity are presented inTable 1. The
results of theGEEs testing the associationbetweenADHDand
hypomania traits arepresented inTable2. SymptomsofADHD
were significantlyassociatedwithhypomaniaat 15yearsof age
(β = 0.30;95%CI,0.26-0.34) and 18yearsof age (β = 0.19;95%
CI, 0.16-0.22) after adjustment for sex and birth year. Re-
moval of hypomania items that were similar to ADHD items
(2 of 10 CMRS items and 5 of 13 Mood Disorders Question-
naire items) did not affect the results (eTable 2 in the Supple-
ment). All diagnostic definitions of ADHD were significantly
associatedwith being at high risk of BD (Table 2). The rates of
clinicallydiagnosedADHDamongthe52 individualswitha for-
maldiagnosisofBDand/oraprescriptionof lithium(37%)were
significantly higher than that among controls (4%) (odds ra-
tio, 15.41; 95% CI, 8.55-27.76; P < .001).
The continuousmeasuresofADHDandhypomanic symp-
toms were used for the remaining analyses. Twin correla-
tions for ADHD and hypomanic traits are given in Table 3; the
univariate twin analyses and fit statistics are presented in
eTable 3 and eTable 4 in the Supplement. The assumption of
equal means and variances across zygosity was not met for
ADHD, suggesting sibling contrast pathways (eTable 3 in the
Supplement). Moderate to strong heritability was found for
ADHD (heritability, 0.51-0.74) and hypomania traits (herita-
bility, 0.50-0.64).
Phenotypic and cross-trait cross-twin correlations are
presented in Table 3. AnA, C, andEmodelwas chosen as best
fitting, with sibling interaction paths for ADHD. The propor-
tions of variation in each hypomania scale that were associ-
ated with genetic and environmental risk factors unique to
hypomaniaandsharedwithADHDtraits are shown inFigure2.
In total, 21% to 22% of the variance in hypomania at 15 years
of age and 13% to 29% at 18 years of age was associated with
Table 1. ADHD andHypomaniaMeasures by Sex and Zygosity
Variable
Mean (SD)
Score
RangeTotal Male Female MZM DZM MZF DZF
DZOS
Male Female
ADHD Assessments
Age, y
9 or 12 2.02 (2.97) 2.47 (3.42) 1.56 (2.61) 2.24 (3.21) 2.55 (3.51) 1.44 (2.43) 1.79 (2.90) 2.56 (3.48) 1.46 (2.47) 0-19
15 1.83 (1.84) 2.11 (1.94) 1.57 (1.71) 1.99 (1.82) 2.08 (1.95) 1.45 (1.62) 1.75 (1.85) 2.23 (2.01) 1.51 (1.64) 0-8
18 2.15 (2.97) 2.43 (3.17) 1.88 (2.74) 2.14 (2.78) 2.41 (3.20) 1.72 (2.50) 2.12 (3.05) 2.75 (3.46) 1.84 (2.68) 0-24
ADHD Subscales
Age of 9 or 12 y
Hyperactivity-
impulsivity
0.97 (1.67) 1.17 (1.85) 0.77 (1.44) 1.09 (1.74) 1.21 (1.91) 0.70 (1.32) 0.87 (1.60) 1.19 (1.86) 0.74 (1.39) 0-10
Inattention 1.05 (1.75) 1.30 (1.93) 0.79 (1.50) 1.16 (1.79) 1.34 (1.98) 0.74 (1.43) 0.92 (1.63) 1.37 (1.98) 0.72 (1.41) 0-9
Age of 18 y
Hyperactivity-
impulsivity
0.73 (1.40) 0.76 (1.43) 0.70 (1.37) 0.65 (1.24) 0.81 (1.50) 0.60 (1.22) 0.82 (1.54) 0.80 (1.52) 0.69 (1.35) 0-12
Inattention 1.42 (1.91) 1.68 (2.07) 1.19 (1.72) 1.49 (1.86) 1.60 (2.03) 1.11 (1.61) 1.31 (1.86) 1.95 (2.27) 1.15 (1.68) 0-13
Hypomania Measures
Age, y
15 1.80 (2.43) 1.60 (2.32) 2.00 (2.53) 1.47 (2.16) 1.66 (2.43) 1.93 (2.37) 2.07 (2.69) 1.66 (2.32) 1.99 (2.52) 0-24
18 0.93 (1.85) 0.91 (1.86) 0.95 (1.85) 0.79 (1.68) 0.93 (1.90) 0.90 (1.75) 0.95 (1.90) 0.99 (1.97) 1.01 (1.92) 0-13
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; DZF, dizygotic
female twin pairs; DZM, dizygotic male twin pairs; DZOS, dizygotic opposite-sex
twin pairs; MZF, monozygotic female twin pairs; MZM, monozygotic male twin
pairs.
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genetic factors shared with ADHD at any age. Nonshared en-
vironmental factors associated with ADHD played a negli-
gible role in hypomania. Hypomania-specific genetic factors
accounted for 25% to 42% of its variance (eTable 5 in the
Supplement). Similar resultswere foundwith the reducedhy-
pomania scales (eTable 6 in the Supplement).
Hyperactivity-impulsivity was more strongly associated
with hypomanic symptoms compared with inattention
(Table 2). Up to 25% of the variance in hypomania was asso-
ciated with genetic risk factors shared with hyperactivity-
impulsivityandupto16%with inattention (Figure2).Themod-
els’ fit statistics and estimates are presented in eTables 7-9 in
theSupplement.Analysesusing the reducedhypomania scales
yielded comparable findings (eTable 10 and eTable 11 in the
Supplement).
Discussion
To our knowledge, thiswas the first twin study to explore the
shared genetic and environmental factors associated with
ADHD and hypomania symptoms in youths. Traits of ADHD
across childhood and adolescence were associated with ado-
lescenthypomania.More thanaquarter of thevariance forhy-
pomania was associated with shared genetic risk factors for
ADHDtraits (range, 13%-29%).Hypomania-specificgenetic risk
factors accounted for 27%to46%of its variance.Environmen-
tal factors played a negligible role in the ADHD-hypomania
symptomassociation.Thegeneticoverlapwithhypomaniawas
larger with hyperactivity-impulsivity (range, 10%-25%) com-
pared with inattention (range, 6%-16%).
The associations between ADHD and hypomanic symp-
tomsobservedhere are similar to those reported inother ado-
lescent samples.2 For example, 1 study28 found that among98
adolescentpatientswithBD,37.8%presentedwithADHD,simi-
lar to the comorbidity rate of 37% in our study. Both ADHD
dimensions were significantly associated with hypomania in
this study, with a stronger association with hyperactivity-
impulsivity. Previous research suggests that both ADHD do-
mains are associated with BD to a similar degree12 or more
strongly with inattention10 using data from adults10 and
outpatients.12 We used a community sample of youths be-
Table 2. Associations Between ADHD andHypomania
Variable β (95% CI)a SE 1-Sided P Value
Association Among ADHD Traits, Diagnoses, and Hypomania
Hypomania age 15 y
ADHD symptoms 0.30 (0.24-0.34) 0.02 <.001
Hyperactive-impulsive
symptoms
0.53 (0.46-0.60) 0.04 <.001
Inattentive symptoms 0.40 (0.34-0.47) 0.03 <.001
Broad cutoff ADHDb 2.26 (1.90-2.61) 0.18 <.001
Strict cutoff ADHDc 3.68 (2.42-4.95) 0.65 <.001
ADHD diagnosisd 3.18 (2.55-3.81) 0.32 <.001
Hypomania at age 18 y
ADHD symptoms 0.19 (0.16-0.22) 0.02 <.001
Hyperactive-impulsive
symptoms
0.36 (0.30-0.42) 0.03 <.001
Inattentive symptoms 0.24 (0.19-0.29) 0.03 <.001
Broad cutoff ADHDb 1.57 (1.24-1.90) 0.17 <.001
Strict cutoff ADHDc 2.54 (1.68-3.39) 0.44 <.001
ADHD diagnosisd 2.88 (2.19-3.56) 0.35 <.001
Association Between Hypomanic Symptoms and ADHD
ADHD at age 15 y
Hypomanic symptoms 1.49 (1.34-1.64) 0.08 <.001
ADHD at age 18 y
Hypomanic symptoms 1.98 (1.79-2.17) 0.10 <.001
Association Between ADHD Diagnoses and High Risk of Bipolar Disordere
Variable Comparison Group/
High-risk Group, No. (%)
Adjusted OR (95% CI)a 1-Sided P Value
Hypomania at age 15 y
Broad cutoff ADHDa 429 (0.07)/36 (38) 8.27 (5.43-12.58) <.001
Strict cutoff ADHDb 56 (0.009)/12 (13) 15.66 (8.02-30.59) <.001
ADHD diagnosisc 165 (0.03)/28 (29) 15.75 (9.81-25.29) <.001
Hypomania at age 18 y
Broad cutoff ADHDa 273 (0.06)/27 (43) 11.95 (7.00-20.40) <.001
Strict cutoff ADHDb 36 (0.008)/7 (11) 15.46 (6.50-36.73) <.001
ADHD diagnosisc 78 (0.02)/20 (32) 28.53 (15.95-51.04) <.001
Abbreviations:
ADHD, attention-deficit/
hyperactivity disorder; BD, bipolar
disorder; OR, odds ratio.
a Adjusted for sex and age.
bBroad ADHD: score of 6 or more on
the Autism-Tics, ADHD, and Other
Comorbidities Inventory ADHD
module at 9 and 12 years of age
(n = 465 [7%] at 15 years of age;
n = 300 [7%] at 18 years of age).
c Strict ADHD: score of 12.5 or more
on the Autism-Tics, ADHD, and
Other Comorbidities Inventory
ADHDmodule at 9 and 12 years of
age (n = 68 [1%] at 15 years of age;
n = 43 [1%] at 18 years of age).
dADHD diagnosis: at least 1 recorded
diagnosis of ADHD in the National
Patient Register (n = 193 [3%] at 15
years of age; n = 98 [2%] at 18 years
of age).
e These data are given as number
(percentage) of comparison group
(n = 6301)/high-risk BD group
(n = 96). High risk of BDwas
defined as a cutoff of 10 or more on
the parent-rated Child Mania Rating
Scale at 15 years of age or a
parent-ratedMood Disorders
Questionnaire score of at least 7
with symptoms clustered together
in the same period andmoderate to
severe problems (eg, work and legal
problems).
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Table 3. Phenotypic, Twin, and Cross-Trait Cross-Twin Correlations for ADHD andHypomania
Variable
rph
Male Female MZM DZM MZF DZF DZOS
Cross-Twin Correlations
Age at ADHD
symptoms onset, y
9 NA NA 0.68 (0.66 to
0.70)
0.24 (0.21 to
0.28)
0.64 (0.61 to
0.66)
0.24 (0.20 to
0.27)
0.32 (0.29 to
0.34)
15 NA NA 0.55 (0.50 to
0.59)
0.12 (0.05 to
0.18)
0.56 (0.52 to
0.60)
0.07 (0.01 to
0.13)
0.14 (0.09 to
0.19)
18 NA NA 0.53 (0.45 to
0.50)
0.24 (0.14 to
0.33)
0.52 (0.45 to
0.59)
0.17 (0.08 to
0.26)
0.22 (0.15 to
0.29)
Age at
hyperactivity-
impulsivity
onset, y
9 or 12 NA NA 0.69 (0.66 to
0.71)
0.19 (0.15 to
0.22)
0.65 (0.62 to
0.67)
0.19 (0.16 to
0.23)
0.24 (0.22 to
0.27)
18 NA NA 0.39 (0.28 to
0.48)
0.14 (0.04 to
0.23)
0.49 (0.41 to
0.56)
0.08 (to 0.02 to
0.17)
0.12 (0.04 to
0.19)
Age at inattention
onset, y
9 or 12 NA NA 0.60 (0.57 to
0.63)
0.14 (0.10 to
0.17)
0.54 (0.51 to
0.56)
0.12 (0.08 to
0.15)
0.20 (0.17 to
0.23)
18 NA NA 0.52 (0.44 to
0.59)
0.19 (0.09 to
0.29)
0.48 (0.40 to
0.55)
0.05 (to 0.05 to
0.14)
0.19 (0.12 to
0.26)
15 NA NA 0.78 (0.75 to
0.81)
0.55 (0.49 to
0.60)
0.77 (0.74 to
0.80)
0.51 (0.45 to
0.57)
0.52 (0.48 to
0.56)
18 0.61 (0.54 to
0.67)
0.29 (0.19 to
0.37)
0.66 (0.60 to
0.70)
0.42 (0.33 to
0.50)
0.30 (0.23 to
0.37)
Cross-Trait Cross-Twin Correlations Between ADHD and Hypomania at Age 15 y
Age at ADHD
symptom onset, y
9 or 12 0.28 (0.24 to
0.31)
0.32 (0.29 to
0.36)
0.26 (0.22 to
0.30)
0.07 (0.02 to
0.12)
0.26 (0.22 to
0.30)
0.13 (0.08 to
0.18)
0.14 (0.10 to
0.17)
15 0.43 (0.40 to
0.43)
0.45 (0.42 to
0.47)
0.36 (0.31 to
0.39)
0.16 (0.15 to
0.21)
0.36 (0.32 to
0.39)
0.19 (0.14 to
0.24)
0.17 (0.14 to
0.21)
18 0.39 (0.34 to
0.44)
0.38 (0.33 to
0.42)
0.31 (0.24 to
0.37)
0.20 (0.13 to
0.28)
0.36 (0.30 to
0.41)
0.21 (0.13 to
0.28)
0.19 (0.14 to
0.25)
Age at
hyperactivity-
impulsivity
onset, y
9 or 12 0.28 (0.25 to
0.32)
0.30 (0.27 to
0.34)
0.28 (0.23 to
0.32)
0.06 (0.05 to
0.11)
0.26 (0.22 to
0.30)
0.11 (0.06 to
0.16)
0.12 (0.09 to
0.15)
18 0.38 (0.33 to
0.43)
0.39 (0.34 to
0.44)
0.29 (0.21 to
0.36)
0.19 (0.12 to
0.27)
0.33 (0.28 to
0.39)
0.15 (0.07 to
0.23)
0.17 (0.11 to
0.23)
Age at inattention
onset, y
9 0.23 (0.19 to
0.26)
0.27 (0.24 to
0.31)
0.20 (0.15 to
0.25)
0.10 (0.04 to
0.15)
0.20 (0.16 to
0.25)
0.13 (0.08 to
0.18)
0.11 (0.07 to
0.15)
18 0.33 (0.27 to
0.38)
0.30 (0.25 to
0.35)
0.27 (0.20 to
0.34)
0.19 (0.11 to
0.27)
0.31 (0.25 to
0.37)
0.19 (0.10 to
0.27)
0.17 (0.11 to
0.22)
Cross-Trait Cross-Twin Correlations Between ADHD and Hypomania at Age 18 y
Age at ADHD
symptom onset, y
9 or 12 0.26 (0.21 to
0.30)
0.31 (0.27 to
0.35)
0.18 (0.13 to
0.24)
0.17 (0.10 to
0.23)
0.27 (0.22 to
0.32)
0.08 (0.02 to
0.15)
0.12 (0.07 to
0.17)
15 0.29 (0.24 to
0.34)
0.35 (0.31 to
0.40)
0.18 (0.11 to
0.25)
0.15 (0.06 to
0.22)
0.31 (0.25 to
0.37)
0.08 (0.00 to
0.15)
0.15 (0.09 to
0.22)
18 0.45 (0.41 to
0.48)
0.51 (0.48 to
0.54)
0.30 (0.23 to
0.35)
0.23 (0.15 to
0.30)
0.42 (0.37 to
0.46)
0.21 (0.13 to
0.28)
0.19 (0.14 to
0.24)
Age at
hyperactivity-
impulsivity
onset, y
9 or 12 0.28 (0.24 to
0.33)
0.32 (0.27 to
0.36)
0.23 (0.17 to
0.28)
0.15 (0.08 to
0.22)
0.29 (0.24 to
0.34)
0.09 (0.02 to
0.16)
0.12 (0.06 to
0.17)
18 0.48 (0.45 to
0.51)
0.52 (0.49 to
0.56)
0.32 (0.25 to
0.39)
0.18 (0.10 to
0.25)
0.41 (0.36 to
0.46)
0.20 (0.12 to
0.27)
0.16 (0.11 to
0.22)
(continued)
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cause the associationbetweenhypomania and theADHDpre-
sentationsmay vary with age and from population to service
level and assessment method.
This investigation provides a novel contribution by ex-
ploring the shared genetic and environmental factors associ-
ated with the ADHD-hypomania overlap in youths, examin-
ing hyperactivity-impulsivity and inattention separately. The
percentage of variance in hypomania that could be associ-
atedwith sharedgenetic factorswithADHDsymptoms (range,
13%-29%) concurs with genetic correlations reported by a
family study14 onBD II andADHD(correlation,0.33) andamo-
lecular genetic study29 (correlation, 0.26).
Our other novel finding is that up to 25% of the variance
in hypomania was associated with genetic factors related to
hyperactivity-impulsivity compared with up to 16% for
inattention.30 This finding is consistent with results showing
that the degree to which ADHD symptom domains share ge-
netic risk factors with other psychopathological dimensions
in youths varies.31
Our findings have important clinical and research impli-
cations. First, our results provide additional evidence of the
ADHD-hypomania symptom overlap in youths, highlighting
the need for early identification and recognition among prac-
titioners, especially given the care needed to avoid the nega-
tiveoutcomesassociatedwithADHD-BDcomorbidity (eg, sui-
cide attempts) compared with when these conditions occur
alone.11-13 Future studies should follow up youths identified
as high risk for BD andwhoexhibit ADHDsymptoms to ascer-
tain whether they develop specific forms of psychopathol-
ogy. Second, significant genetic factors play a role in adoles-
cent hypomania that are distinct fromADHD, suggesting that
thesephenotypes arenot an extensionof one another.Our re-
sults build on the ADHDandhypomania etiologicmodels, in-
dicating shared genetic factors associated with these disor-
ders. Uncovering the specific nature of the genetic overlap
between these phenotypes should be the focus of further
research.
Strengths and Limitations
Strengths of this study include the use of a large, longitudinal,
genetically informativesample;useofnationwideregistries;and
the distinction between the ADHD symptomdomains in asso-
ciation with adolescent hypomanic traits; however, there are
some limitations.First, hypomaniawasnotmeasured in child-
hood; thus, the association between earlier hypomanic symp-
tomsandADHDtraits across childhoodandadolescence could
notbeassessed.Second,hypomanicandADHDsymptomswere
measured using different instruments at each age, whichmay
have affected the results. Both hypomania measures are con-
sidered among the best-validated and most discriminating
adolescent BD instruments.32 The ADHDmeasures have good
psychometric properties and are widely used.
Also, there has been much debate surrounding the over-
lap between ADHD and hypomania,7 particularly concerning
their symptomsimilarity. In the current study, significant cor-
relations between hypomania andADHD symptomswere de-
tected evenwhenoverlapping symptomswere removed from
the hypomania scales, but various factorsmay still confound
Table 3. Phenotypic, Twin, and Cross-Trait Cross-Twin Correlations for ADHD andHypomania (continued)
Variable
rph
Male Female MZM DZM MZF DZF DZOS
Age at inattention
onset, y
9 or 12 0.22 (0.18 to
0.26)
0.25 (0.20 to
0.29)
0.14 (0.08 to
0.20)
0.15 (0.09 to
0.22)
0.20 (0.15 to
0.26)
0.06 (−0.01 to
0.12)
0.10 (0.05 to
0.15)
18 0.38 (0.34 to
0.42)
0.43 (0.40 to
0.47)
0.24 (0.18 to
0.30)
0.21 (0.14 to
0.28)
0.36 (0.31 to
0.41)
0.16 (0.09 to
0.23)
0.17 (0.12 to
0.22)
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; DZF, dizygotic
female twin pairs; DZM, dizygotic male twin pairs; DZOS, dizygotic opposite-sex
twin pairs; MZF, monozygotic female twin pairs; MZM, monozygotic male twin
pairs; NA, not applicable; rph, phenotypic correlation.
Figure 2. Proportion of theGenetic andNonshared Environmental Risk Factors for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD),
Hyperactivity-Impulsivity, and InattentionAcross Childhood andAdolescence That AreAssociatedWith theVariation in AdolescentHypomania by Sex
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these associations. For instance, sharedmethodvariancemay
have inflated the associations because both phenotypeswere
measured using questionnaires.33
Several associated features of ADHD (eg, irritability and
emotional liability) not included in its diagnostic criteria over-
lap with hypomania.7 These features were not accounted for
here, whichmay have affected the ADHD-hypomania associa-
tions reported and should be considered in future research.
Questionnaires are a practical data collectionmethod for large
samplesneededtoundertaketwinresearch.However, theyhave
various limitations, such as the reliance on a restricted num-
berof items that sometimes lackcontext.Given thatADHDand
hypomania were assessed using a restricted number of items,
only 2 of 10 items for the CMRS and 5 of 13 for theMoodDisor-
dersQuestionnaireoverlappedbetween thesephenotypesand
were removed to account for symptomsimilarity. It is possible
that some overlapping symptomswere notmeasured.
Whether the presentation of overlapping symptoms is
chronicorepisodic is crucial todeterminingwhether thesymp-
toms are characteristic of ADHD or hypomania but was not
clarified in all instrumentsused in this study (eg,CMRS). Stan-
dardized diagnostic interviews are a more comprehensive
approach to establish the specific nature of the symptompre-
sentation and should be adopted by future studies.
TheADHD-BDcomorbiditywas assessedusingofficial di-
agnoses in the Swedish National Patient Register, but this
method has several shortcomings that can inflate the comor-
bidity rate, although it was comparable to that in another
study.28These shortcomings include lowagreementwithstan-
dardized diagnostic interviews34 and questionable interrater
reliability, particularly for BD.35,36When BD ismisdiagnosed,
it is frequentlymisdiagnosed asADHD,37which affects the ac-
curacy of the ADHD-BD comorbidity rate detected.
Conclusions
To our knowledge, this was the first study to examine the
shared genetic and environmental factors associated with
ADHD traits across childhood and adolescence and adoles-
cent hypomania in a representative, longitudinal twin co-
hort. The collective genetic risk factors for ADHD across
childhood and adolescence may also be associated with hy-
pomanic symptoms. The observed associations were stron-
ger between hypomania and hyperactivity-impulsivity com-
paredwith inattention,but theassociationbetween inattention
andhypomaniawasmoderateandsignificant.This findingsug-
gests that the overlap betweenADHDandhypomania traits is
likely to reflect a genetic linkbetween thesephenotypes.Nev-
ertheless, a substantial amount of the variance for hypoma-
niawasassociatedwithgenetic risk factors thatwerenotshared
with ADHD.
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